Pro Quantitative Proteomics

Pro Quantitative Proteomics

Proteomics

Product Overview

With the advancement of protein analysis technology and mass spectrometry performance, DIA quantification methods in proteomics have evolved from the initial DIA to 4D-DIA and then to Astral Zoom DIA. Data analysis has also progressed from initially referencing DDA spectral libraries to database-independent retrieval and then to combining machine learning to assist in the analysis of raw DIA mass spectrometry spectra. This has enabled DIA quantification to combine the advantages of high throughput, high depth, and high accuracy, making it the mainstream analytical technique in proteomics analysis. Its application range covers routine samples, clinical samples, trace samples, and single-cell samples.

DDA & DIA

The DDA method randomly selects and prefers peptides with high signal intensity for fragmentation and data acquisition, making the identification and quantification of low-abundance peptides a significant challenge. The DIA method divides all peptides into several windows based on molecular weight, without distinguishing peptides within each window by abundance. All peptides within a window are fragmented and data acquired together, ensuring comprehensive and consistent mass spectrometry data collection for all peptides.

Pro protein 1@2x.jpg

Schematic diagrams of DDA and DIA methods. All mass spectra acquired by DDA originate from high-abundance single peptides, while DIA acquires mixed peptide spectra containing low-abundance peptides

Pro-DIA(4D)

Pro-DIA (4D) is a DIA technology based on the timsTOF HT ion mobility platform. It adds a fourth dimension—ion mobility—to traditional DIA. Ion mobility primarily separates ions based on their shape and cross-section, enabling the differentiation of peptides with very small m/z differences, thus allowing the identification and recognition of low-abundance protein signals. Combining PASEF (Parallel Accumulation Serial Fragmentation) and TIMS (Ion Mobility Spectroscopy), Pro-DIA allows for repeated measurement of the collision cross-section (CCS) of all detected ions, enabling faster and more sensitive qualitative and quantitative proteomics analysis. Compared to traditional methods, it comprehensively improves protein identification coverage, reproducibility, and quantitative accuracy.

Pro protein 2@2x.jpg

4D-DIA Analysis Flowchart


Plus-DIA(Zoom)

Astral Zoom, an upgraded version of Astral, achieves a perfect balance of high throughput, deep coverage, high sensitivity, and high reliability in quantification. The Plus-DIA quantitative omics platform enables deeper identification with fewer samples, supporting more comprehensive protein sequence coverage and pathway annotation, thereby revealing more biological information.

Pro protein 3@2x.jpg

Compared to the Astral mass spectrometer, the Astral Zoom mass spectrometer offers greater depth of coverage for proteins and peptides.

(Data source: Official website)




Analysis Process


Analysis Process

Pro Quantitative Proteomics Analysis Process

Sample Submission Requirements

Sample Type
Suspension Culture Cells
Sample Quantity
0.5-10 million, repeated ≥3 times
Sample Type
Adherent Cell Culture
Sample Quantity
0.5-10 million, repeated ≥3 times
Sample Type
Cell Culture Supernatant
Sample Quantity
5-10 mL, repeated ≥3 times
Sample Type
Soft Tissues (brain, liver, muscles, etc.)
Sample Quantity
10-50mg, ≥6 in animals, >15 in clinical trials
Sample Type
Molluscs (nematodes, schistosomes, etc.)
Sample Quantity
50-100mg, ≥6 in animals, >15 in clinical trials
Sample Type
Adipose Tissue (white)
Sample Quantity
0.1-1g, ≥6 in animals, >15 in clinical trials
Sample Type
Tough Tissue - Cartilage
Sample Quantity
50-200mg, ≥6 in animals, >15 in clinical trials
Sample Type
Tough Tissue - Bone
Sample Quantity
0.1-1g, ≥6 in animals, >15 in clinical trials
Sample Type
Tough Tissue - Hair
Sample Quantity
50-200mg, ≥6 in animals, >15 in clinical trials
Sample Type
Serum/Plasma
Sample Quantity
100-300ul, ≥6 in animals, >15 in clinical trials
Sample Type
Cerebrospinal fluid, Synovial fluid, Lymphatic fluid, Epididymal fluid
Sample Quantity
50-200ul, ≥6 in animals, >15 in clinical trials
Sample Type
Saliva, Tears
Sample Quantity
100-500ul, ≥6 in animals, >15 in clinical trials
Sample Type
Urine
Sample Quantity
3-10ml, ≥6 in animals, >15 in clinical trials
Sample Type
FFPE
Sample Quantity
10µm × 1cm^2,≥6 in animals, >15 in clinical trials
Sample Type
Plant Soft Tissue
Sample Quantity
100-500mg, repeated ≥6 times
Sample Type
Woody tree roots, bark, branches, etc.
Sample Quantity
0.3-1g, repeated ≥6 times
Sample Type
Fruits, Seeds
Sample Quantity
100-200mg, repeated ≥6 times
Sample Type
Pollen
Sample Quantity
50-100mg, repeated ≥6 times
Sample Type
Fungi (fungal cell sediment)
Sample Quantity
10-50 million doses / 0.1-2g, repeat ≥3 times

Shenzhen Wininnovate Bio Co., Ltd.

Innovative mass spectrometry and AI technologies provide protein and metabolite mass spectrometry multi-omics solutions for life science research, empowering the growth of the biotechnology, pharmaceutical, and healthcare industries.

Free trial
Free trial
Fast delivery
Fast delivery
1-on-1 account service
1-on-1 account service
24/7 support
24/7 support